2911 - 2920 of 6557 Results
Title
Year
-
OPENTitle: The Michael J. Fox Foundation’s Strategies for Accelerating Translation of LRRK2 into Therapies for Parkinson DiseaseJournal Name: CellsPublisher: MDPI AGVol: 9Issue #: 8Start Page: 1878End Page: 1878Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells9081878Best OA location URL: https://www.mdpi.com/2073-4409/9/8/1878/pdf?version=1597644425Citation Count: 6
- Early nucleus basalis of Meynert degeneration predicts cognitive decline in Parkinson’s disease2017OPENTitle: Early nucleus basalis of Meynert degeneration predicts cognitive decline in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 141Issue #: 1Start Page: 7End Page: 10Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awx333Best OA location URL: https://academic.oup.com/brain/article-pdf/141/1/7/24175740/awx333.pdfCitation Count: 19
-
OPENTitle: Robust Ensemble Classification Methodology for I123-Ioflupane SPECT Images and Multiple Heterogeneous Biomarkers in the Diagnosis of Parkinson's DiseaseJournal Name: Frontiers in NeuroinformaticsPublisher: Frontiers Media SAVol: 12Issue #:Start Page: 53End Page: 53Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fninf.2018.00053Best OA location URL: https://www.frontiersin.org/articles/10.3389/fninf.2018.00053/pdfCitation Count: 54
-
OPENTitle: High-throughput neuroimaging-genetics computational infrastructureJournal Name: Frontiers in NeuroinformaticsPublisher: Frontiers Media SAVol: 8Issue #:Start Page: 41End Page: 41Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fninf.2014.00041Best OA location URL: https://escholarship.org/uc/item/6fd5s8h0Citation Count: 29
-
OPENTitle: Modeling long-term health and economic implications of new treatment strategies for Parkinson’s disease: an individual patient simulation studyJournal Name: Journal of Market Access & Health PolicyPublisher: MDPI AGVol: 9Issue #: 1Start Page: 1922163End Page: 1922163Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/20016689.2021.1922163Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/20016689.2021.1922163?needAccess=trueCitation Count: 5
-
OPENTitle: APOE genotype regulates pathology and disease progression in synucleinopathyJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 12Issue #: 529Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aay3069Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7289511Citation Count: 181
-
OPENTitle: BLENDS: Augmentation of Functional Magnetic Resonance Images for Machine Learning Using Anatomically Constrained WarpingJournal Name: Brain ConnectivityPublisher: SAGE PublicationsVol: 13Issue #: 2Start Page: 80End Page: 88Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1089/brain.2021.0186Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10039274/pdf/brain.2021.0186.pdfCitation Count: 3
- Ca 2+ channels couple spiking to mitochondrial metabolism in substantia nigra dopaminergic neurons2022OPENTitle: Ca 2+ channels couple spiking to mitochondrial metabolism in substantia nigra dopaminergic neuronsJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 8Issue #: 39Start Page: eabp8701End Page: eabp8701Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.abp8701Best OA location URL: https://doi.org/10.1126/sciadv.abp8701Citation Count: 84
-
OPENTitle: How should we be using biomarkers in trials of disease modification in Parkinson’s disease?Journal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 12Start Page: 4845End Page: 4869Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awad265Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad265/51034903/awad265.pdfCitation Count: 49
- Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease2016OPENTitle: Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 7End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-016-0072-9Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0072-9Citation Count: 290